To study the demographic profile of HCC patients and the pattern of clinical characteristics in a tertiary care centre of north western India
Main Article Content
Abstract
Hepatocellular carcinoma (HCC) is a prevalent malignancy globally and the fifth most common cancer worldwide. This retrospective study, spanning six years, explores the shifting etiological patterns of HCC in Northwestern India, particularly influenced by factors like Hepatitis B and C endemics, alcohol consumption, and vaccination programs. Data from 164 HCC patients reveal a significant shift, with Hepatitis C surpassing Hepatitis B as the primary etiological factor. The study highlights the distinctive HCC profile in Northwestern India, emphasizing the imperative to address HCV as a silent precursor to HCC and the need for enhanced surveillance and intervention strategies. The findings underscore the significance of controlling alcohol abuse, managing cirrhosis complications, and the urgency for improved diagnostic markers beyond AFP. The study prompts a reevaluation of vaccination interventions and advocates for heightened screening measures to detect and mitigate HCV-related HCC at earlier stages.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Acharya SK. Epidemiology of hepatocellular carcinoma in India. Journal of clinical and experimental hepatology. 2014 Aug 1;4:S27-33.
Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM: An International Journal of Medicine. 2008 Jun 1;101(6):479-85.
Bhattacharyya GS, Babu KG, Malhotra H, Ranade AA, Murshed S, Datta D. Hepatocellular carcinoma in India. Chinese Clinical Oncology. 2013 Apr 12;2(4).
Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, Das BC. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. Journal of gastroenterology and hepatology. 2001 Jun;16(6):666-73.
Kumar A, Acharya SK, Singh SP, Arora A, Dhiman RK, Aggarwal R, Anand AC, Bhangui P, Chawla YK, Gupta SD, Dixit VK. 2019 Update of Indian National Association for the study of the liver consensus on prevention, diagnosis, and management of hepatocellular carcinoma in India: the puri II recommendations. Journal of clinical and experimental hepatology. 2020 Jan 1;10(1):43-80.
Paul SB, Chalamalasetty SB, Vishnubhatla S, Madan K, Gamanagatti SR, Batra Y, Gupta SD, Panda SK, Acharya SK. Clinical profile, etiology, and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77(3-4):162-71.